本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

4.99
-0.0500-0.99%
盤後4.80-0.1900-3.81%19:30 EDT
成交量:3.45萬
成交額:17.21萬
市值:3,116.06萬
市盈率:-0.68
高:5.45
開:5.04
低:4.82
收:5.04
52周最高:13.69
52周最低:3.98
股本:624.46萬
流通股本:370.27萬
量比:0.83
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
淨資產收益率:-113.59%
總資產收益率:-49.12%
市淨率:0.98
市盈率(LYR):-2.04

資料載入中...

2021/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/27

重要事件披露

8-K - Current report
2021/03/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/23

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/30

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/20

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/20

重要事件披露

8-K - Current report